188 related articles for article (PubMed ID: 31016730)
1. Treatment and outcome of Unicentric Castleman Disease: a retrospective analysis of 71 cases.
Boutboul D; Fadlallah J; Chawki S; Fieschi C; Malphettes M; Dossier A; Gérard L; Mordant P; Meignin V; Oksenhendler E; Galicier L
Br J Haematol; 2019 Jul; 186(2):269-273. PubMed ID: 31016730
[TBL] [Abstract][Full Text] [Related]
2. Unicentric Castleman Disease.
Wong RSM
Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
[TBL] [Abstract][Full Text] [Related]
3. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
Chronowski GM; Ha CS; Wilder RB; Cabanillas F; Manning J; Cox JD
Cancer; 2001 Aug; 92(3):670-6. PubMed ID: 11505414
[TBL] [Abstract][Full Text] [Related]
4. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
Bowne WB; Lewis JJ; Filippa DA; Niesvizky R; Brooks AD; Burt ME; Brennan MF
Cancer; 1999 Feb; 85(3):706-17. PubMed ID: 10091744
[TBL] [Abstract][Full Text] [Related]
5. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
[TBL] [Abstract][Full Text] [Related]
6. Castleman Disease.
Wang W; Medeiros LJ
Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital.
González-García A; Patier de la Peña JL; García-Cosio M; Sarhane Y; Sánchez Díaz C; Barbolla Díaz I; López Rodríguez M; Moreno MÁ; Villarubia J; Manzano L
Leuk Lymphoma; 2019 Dec; 60(14):3442-3448. PubMed ID: 31305183
[TBL] [Abstract][Full Text] [Related]
8. Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
Abid MB; Peck R; Abid MA; Al-Sakkaf W; Zhang Y; Dunnill GS; Staines K; Sequeiros IM; Lowry L
Hematol Oncol; 2018 Feb; 36(1):320-323. PubMed ID: 28401573
[TBL] [Abstract][Full Text] [Related]
9. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Castleman Disease.
Abramson JS
J Natl Compr Canc Netw; 2019 Nov; 17(11.5):1417-1419. PubMed ID: 31766018
[TBL] [Abstract][Full Text] [Related]
11. Induction immunotherapy followed by surgery for hilar unicentric Castleman disease.
Shoji F; Takase K; Kozuma Y; Yamazaki K; Kawauchi S; Takeo S
Thorac Cancer; 2022 Jun; 13(11):1722-1725. PubMed ID: 35437953
[TBL] [Abstract][Full Text] [Related]
12. A Rare Lymphoproliferative Disease: Castleman Disease.
Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
[TBL] [Abstract][Full Text] [Related]
13. [Castleman disease: retrospective single-center study of therapeutic results in 10 patients].
Szturz P; Adam Z; Rehák Z; Koukalová R; Sprláková-Puková A; Michalka J; Smardová L; Volfová P; Lengerová M; Mayer J
Klin Onkol; 2013; 26(2):124-34. PubMed ID: 23718671
[TBL] [Abstract][Full Text] [Related]
14. Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease.
Beckham TH; Yang JC; Chau KW; Noy A; Yahalom J
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):685-689. PubMed ID: 32522439
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.
Zhang X; Rao H; Xu X; Li Z; Liao B; Wu H; Li M; Tong X; Li J; Cai Q
Cancer Sci; 2018 Jan; 109(1):199-206. PubMed ID: 29124835
[TBL] [Abstract][Full Text] [Related]
16. The role of surgical resection in Unicentric Castleman's disease: a systematic review.
Mitsos S; Stamatopoulos A; Patrini D; George RS; Lawrence DR; Panagiotopoulos N
Adv Respir Med; 2018; 86(1):36-43. PubMed ID: 29490420
[TBL] [Abstract][Full Text] [Related]
17. Surgery in Castleman's disease: a systematic review of 404 published cases.
Talat N; Belgaumkar AP; Schulte KM
Ann Surg; 2012 Apr; 255(4):677-84. PubMed ID: 22367441
[TBL] [Abstract][Full Text] [Related]
18. Thoracic Paraspinal Castleman Disease in a Young Mexican-American Man with Postcoital Hematuria.
Foster CH; Elahi C; Cheney S; Trier T; Torabi A; Manglik N
World Neurosurg; 2018 Dec; 120():36-42. PubMed ID: 30165219
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial treatment for unresectable unicentric Castleman disease.
Mohan M; Meek JC; Meek ME; Broadwater R; Alapat D; van Rhee F
Eur J Haematol; 2021 Oct; 107(4):484-488. PubMed ID: 34242421
[TBL] [Abstract][Full Text] [Related]
20. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
Li P; Liu H; Li H; Li A; Yu G; Yin W
Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
